FdaApplication
ANDA 216007
Identifiers
- fda_app_no: ANDA216007
Properties
| Property | Value |
|---|---|
| applicant_name | CHENGDU SHUODE PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2023-11-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALMEFENE HYDROCHLORIDE | NALMEFENE HYDROCHLORIDE | EQ 2MG BASE/2ML (EQ 1MG BASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| NALMEFENE HYDROCHLORIDE | NALMEFENE HYDROCHLORIDE | 2MG BASE/2ML (EQ 1MGBASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| NALMEFENE HYDROCHLORIDE | NALMEFENE HYDROCHLORIDE | EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
3 products